What are killer cells and what do they do?

This publication has 70 references indexed in Scilit:

• Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
  Immunology Today, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune System
  Annual Review of Immunology, 1987
• THE CONTRIBUTION OF LARGE GRANULAR LYMPHOCYTES TO B CELL ACTIVATION AND DIFFERENTIATION AFTER T-CELL-DEPLETED ALLOGENEIC BONE MARROW TRANSPLANTATION
  Transplantation, 1986
• Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
  The Journal of Experimental Medicine, 1985
• Lymphotoxin redux
  Immunology Today, 1985
• Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA
  Nature, 1983
• Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
  Journal of Clinical Investigation, 1980
• ASSOCIATION BETWEEN PRE-TRANSPLANT NATURAL KILL AND GRAFT-VERSUS-HOST DISEASE AFTER STEM-CELL TRANSPLANTATION
  The Lancet, 1979